Aijun Wang received his Ph.D. in Biology from the School of Life Sciences, Tsinghua University, in 2007 and finished his postdoctoral training at the University of California Berkeley in 2011. He joined the University of California, Davis (UC Davis) in 2012 and is currently a Chancellor’s Fellow Professor of Surgery and Biomedical Engineering at UC Davis. His research interests mainly focus on developing tools, technologies, and products that combine molecular, cellular, tissue, and biomaterial engineering to promote regeneration and restore function. Specifically, his lab is currently focused on engineering stem cell/gene therapy, extracellular vesicles/nanomedicine, and extracellular matrix/biomaterial scaffolds to develop clinically adaptable theranostics for treating neurological and vascular disorders and diseases.
the 2012 Deloitte QB3 Award for Innovation
California Institute for Quantitative Bioscience (QB3)
Best of ASH 2014
American Society of Hematology (ASH) 2014 Annual Meeting
The Tony Phillips Research Award
The Children’s Miracle Network (CMN)
The Basil O’Connor Starter Scholar Research Award
The March of Dimes Foundation
NIH/NHLBI Technology Development Award
University of California Center for Accelerated Innovation (UC-CAI)
Dean’s Fellow in Entrepreneurship
University of California Davis School of Medicine
Deans’ Team Award for Excellence in Research
University of California Davis Health
Chancellor’s Fellow
University of California Davis
KidneyX: Redesign Dialysis Phase 2 Award
The American Society of Nephrology (ASN) and the Department of Health and Human Services (HHS)